Millipore Sigma Vibrant Logo

662096 Ubiquitin Protein Conjugation Kit

Ubiquitin Protein Conjugation Kit: SDB (Sicherheitsdatenblätter), Analysenzertifikate und Qualitätszertifikate, Dossiers, Broschüren und andere verfügbare Dokumente.
662096
  
Preis wird abgerufen...
Preis nicht abrufbar
Die Mindestmenge muss ein Vielfaches sein von
Maximum Quantity is
Bei Bestätigung Weitere Informationen
Sie haben () gespart
 
—
Bitte erfragen
—
Eingeschränkte Verfügbarkeit Eingeschränkte Verfügbarkeit
Lieferbar 
Produkt wurde eingestellt
Begrenzter Lagerbestand
Bestätigung der Verfügbarkeit erforderlich
    Restmenge: Angebot folgt
      Restmenge: Angebot folgt
      Bitte erfragen
      Kontakt zum Kundenservice
      Contact Customer Service

       

      Kontakt zum Kundenservice

      Übersicht

      Replacement Information
      Description
      Overview

      This product has been discontinued.





      Useful for the formation of ubiquitinated proteins that are labeled or immuno-detectable. Has been shown to work with typical iodinated substrate proteins such as lysozyme and β-lactoglobulin. Addition of Ubiquitin Aldehyde (Cat. No. 662056) is recommended for the inhibition of ubiquitin C-terminal hydrolase and to improve conjugate yield. Fractions do not contain 20S, 26S, or any other conjugate or protein degradation activity. Each kit includes two enzyme fractions, ubiquitin, ATP solution, and a user protocol.
      Catalogue Number662096
      Brand Family Calbiochem®
      References
      Product Information
      Kit containsConjugation Fraction #1, Conjugation Fraction #2, Ubiquitin, Energy Solution, and a user protocol.
      Applications
      Biological Information
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Intended useThe Calbiochem® Ubiquitin Protein Conjugation Kit is intended for the in vitro preparation of ubiquitinated proteins that are labeled or can be used for immunodetection.
      Storage and Shipping Information
      Ship Code Dry Ice Only
      Toxicity Standard Handling
      Storage ≤ -70°C
      Storage ConditionsUpon arrival, store the entire contents of the kit at -70°C. After thawing, keep on ice prior to use. For best results, aliquot and freeze. AVOID REPEATED FREEZE/THAW CYCLES.
      Avoid freeze/thaw Avoid freeze/thaw
      Do not freeze Ok to freeze
      Packaging Information
      Transport Information
      Supplemental Information
      Kit containsConjugation Fraction #1, Conjugation Fraction #2, Ubiquitin, Energy Solution, and a user protocol.
      Specifications
      Global Trade Item Number
      Bestellnummer GTIN
      662096 0

      Documentation

      Ubiquitin Protein Conjugation Kit Analysenzertifikate

      TitelChargennummer
      662096

      Broschüre

      Titel
      Caspases and other Apoptosis Related Tools Brochure
      Proteasome/Ubiquitination NF-kB Pathway Brochure

      Literaturstellen

      Titel
    • Shamoto-Nagai, M., et al. 2004. Journal of Neural Transmission 111, 1253.
    • Hu, X., et al. 2002. Journal of Biological Chemistry 277, 16528.
    • Peters, P., et al. (2002) Nature Cell Biology 4, 240.
      		•
      Anwenderprotokoll

      Revision25-June-2008 JSW
      StorageUpon arrival, store the entire contents of the kit at -70°C. After thawing, keep on ice prior to use. For best results, aliquot and freeze. AVOID REPEATED FREEZE/THAW CYCLES.
      Intended useThe Calbiochem® Ubiquitin Protein Conjugation Kit is intended for the in vitro preparation of ubiquitinated proteins that are labeled or can be used for immunodetection.
      Principles of the assayThe Calbiochem® Ubiquitin Protein Conjugation Kit is supplied with the full compliment of purified conjugation enzymes (E1, E2s, and E3s) that are found in Fraction II. The enzymes have been tested and shown to work with typical iodinated "n-end rule" substrates proteins such as lysozyme and β-lactoglobulin. These conjugation fractions contain ubiquitin C-terminal hydrolases. The addition of Ubiquitin Aldehyde (Cat. No. 662056) is recommended for the inhibition of UCHs and to improve overall conjugate yield. The supplied fractions do not contain 20S, 26S, or any other conjugate or protein degradation activity.
      Materials provided• Conjugation Fraction #1 (Kit Component No. KP8801): 1 vial, 125 µl, supplied at 800 µg/ml
      • Conjugation Fraction #2 (Kit Component No. KP8802): 1 vial, 125 µl, supplied at 800 µg/ml
      • Ubiquitin (Kit Component No. KP8803): 1 vial, 25 µl, supplied at 20 mg/ml (2.35 mM) in 150 mM NaCl, 50 mM HEPES, 500 µM DTT, pH 7.6.
      • Energy Solution (Kit Component No. KP8804): 1 vial, 75 µl, supplied as a 10X concentrated solution
      Detailed protocolNote: Individual results may vary with different conditions and substrates.

      1. Combine assay components as follows:

      Table 1: Assay Components


      2. If Ubiquitin Aldehyde is being used, pre-incubate for 5 min at 37°C to allow for inhibition of UCHs.
      3. Initiate conjugation reaction by addition of radiolabeled substrate. Mix by vortexing gently.
      4. Incubate 0.5-4 h at 37°C, depending on individual conditions and requirements. Taking 0.5-1 h time points during the first experiment is recommended for determination of optimal incubation times. Quench time points with EDTA, 10 mM final concentration. Note: DO NOT use these quenched samples for degradation assay.
      5. Run SDS-PAGE gel to determine conjugate formation. Identify optimal conditions.
      6. Once optimal conditions have been determined, the reaction mixture may be aliquoted and frozen for future use, or if desired, conjugates can be further purified using a spin column (G-50). DO NOT quench with EDTA.
      7. Final samples should be counted and run on a gel. Appropriate aliquots should be made and frozen at -80°C. The addition of a co-solvent (PEG, Sucrose or Glycerol) is optional.
      Registered TrademarksCalbiochem® is a registered trademark of EMD Chemicals, Inc.
      Interactive Pathways™ is a trademark of EMD Chemicals, Inc.